PhaseV
PhaseV, a Boston-based medical organization, innovates clinical trials with advanced tools and data insights for efficient therapy delivery.
Founded
2023PhaseV, a Boston-based medical organization, innovates clinical trials with advanced tools and data insights for efficient therapy delivery.
phasevtrials.comCrawled Oct 15, 2026
Quantifying the impact of biomarkers on clinical outcomes, identifying key pathways and mediators, and enabling "what if" scenarios for informed R&D, combination therapies, and optimal indication selection.
PhaseV's platform offers features found in traditional feasibility and site selection platforms and applies causal machine learning and optimization to clinical operations.
Uncover key drivers of heterogeneity, predict outcomes, and optimize recruitment with Response Optimizer—helping sponsors rescue trials, improve success rates, and maximize asset value.
PhaseV is a Boston-based technology company with an enterprise-ready multimodal AI/ML platform for clinical development. It says it has raised over $65M from Accel, Insight, and others.
The company is hiring an Applied AI Engineer to use AI in designing, optimizing, and running clinical trials. The role is part of a team spanning engineering, data science, and product.
The company seeks a Biological Data Scientist with expertise in biological systems modeling, computational methods, and data science. The role focuses on mathematical modeling of biological networks and processes for its drug development platform.
The role reports to the Head of Strategy and Transformation and works with PhaseV's leadership team on marketing strategies, sales pipeline development, sales enablement, and ROI.
PhaseV empowers biopharma sponsors and CROs with AI/ML-driven solutions for fast, efficient, and accurate clinical development decisions.